Home / Market / Company Snapshot

Sun Pharmaceuticals Industries Ltd

HSL Code: SUNPHA | BSE Code: 524715 | NSE Symbol: SUNPHARMA | ISIN: INE044A01036

Fetching Data...

research reports

Sun Pharmaceutical Industries Ltd 7 Feb | 15:41
Q3FY11 Result Update
Q3FY12 Result Update - Sun Pharmaceutical Industries Ltd (SPIL) 6 Mar | 11:50
SPIL recently reported reported better-than-expected Q3FY12 results buoyed by strong performance by its US subsidiary Taro
Q2FY12 Result Update - Sun Pharmaceutical Industries Ltd (SPIL) 16 Nov | 12:57
SPIL recently reported reported better-than-expected Q2FY12 results

news

May15	Corporate News on Tuesday 12:58 Sun Pharmaceutical Industries to consider dividend 553910
Apr24	Corporate News on Tuesday 14:25 Sun Pharma announces USFDA approval for generic Zyprexa tablets 548882
Apr24	Hot Pursuit on Tuesday 14:12 Sun Pharma inches up on USFDA nod for a generic drug 548873
Apr19	Hot Pursuit on Thursday 09:28 Sun Pharma gains 3.2% in 2 days 547946
Apr18	Hot Pursuit on Wednesday 10:10 Sun Pharma hits record high as US top court rules in favor of its unit on patent 547741

Key Ratios

Market Cap (Rs. in Cr.)	60,344.41
Book Value	91.57
EPS (TTM)	21.34
Price/Book	6.36
Face value	1.00
P/E	27.31
Div(%)	350.00
Div Yield(%)	0.60

Fetching Data...

Rs. Cr.	Dec 11	Sep 11	Jun 11
Total Income	2,058.79	1,971.14	1,701.03
Total Expenses	1,181.36	1,110.56	1,088.28
EBITDA	877.43	860.58	612.75
EBIT	800.01	793.82	548.03
PBT	859.12	835.54	579.58
PAT	795.69	707.44	565.31
Net Profit	668.30	597.74	501.00

Values Based on Consolidated Data

Peer Group

More Compare

Dr Reddy`s Labs (NSE) 1,663.45(0.25%)
Cipla (NSE) 321.80(-0.91%)
Ranbaxy Labs. (NSE) 492.00(-0.15%)
Cadila Health. (NSE) 782.35(-2.55%)
Glenmark Pharma. (NSE) 349.35(-4.33%)

Shareholding Pattern

	Promoters	63.72%
	Mutual Funds / UTI	1.88%
	FI / Banks	3.64%
	Insurance	0.00%
	Government	0.00%
	FII	19.97%
	Others	10.80%

Announcements & Events

Announcements
events

Apr24	Sun Pharma announces USFDA approval for generic Zyprexa tablets
Apr21	Sun Pharmaceuticals received tentative approval for the Ibandronate Sodium injection
Apr3	Sun Pharmaceutical Industries` director resigns
Mar28	Sun Pharma announces USFDA approval for generic Seroquel tablets
Mar1	Sun Pharma announces USFDA approval for generic Zyprexa Zydis tablets

MF holdings

Scheme Name	%AUM	CMV(Rs. Cr)
ICICI Pru Dynamic Plan (G)	2.72	111.97
HDFC Top 200 Fund (D)	0.96	109.26
UTI-Mastershare (D)	3.92	92.33
UTI-Equity Fund (D)	4.23	85.49
UTI-Opportunities Fund (D)	2.94	82.64

Exchange Information

NSE Indices		BSE Indices
Nifty		Sensex
CNX 100		BSE 100
CNX 200		BSE 200
S&P CNX 500		BSE 500
CNX Midcap		BSE Mid-Cap
CNX Midcap 50		BSE Small-Cap

Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Comparative performance

	1M (%)	3M (%)	6M (%)
Sun Pharmaceuticals Industries Ltd	0.74	7.59	18.94
NIFTY (S&P CNX)	-5.42	-10.65	-2.48
BSE Sensex	-4.80	-10.30	-3.28
BSE 500	-6.13	-10.20	-1.74

F & O Quotes

Futures
Options

Expiry Date

583.00 -12.90(-2.16%)

Open Price (Rs.)	594.95	No. of Contracts Traded	1167
High Price (Rs.)	597.75	Turnover (Rs. in lakhs)	3,422.14
Low Price (Rs.)	581.00	Open Interest	18,11,500.00
Prev. Close (Rs.)	584.65	Open Int. Chg	-68,500

Key Personnel
Dilip S Shanghvi Chairman & Managing Director Sudhir V Valia Whole-time Director Sailesh T Desai Whole-time Director

Key Address

Registered Office:
Sun Pharma.Inds.
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat.
Tel : 91-265-5515500/5515600
Fax : 91-265-2354897

Email : secretarial:sunpharma.com
Website : http://www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
Add. :C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078.